Are young Iranian women with metabolically healthy obesity at increased risk of CVD incidence?
Jovens iranianas obesas metabolicamente saudáveis têm maior risco de incidência de DCV?
Seyed Ahmad Hosseini; Vahideh Aghamohammadi; Damoon Ashtary-Larky; Meysam Alipour; Matin Ghanavati; Nasrin Lamuchi-Deli
Abstract
Keywords
Resumo
Resumo:
Palavras-chave
References
Kolahi AA, Moghisi A, Soleiman Ekhtiari Y. Socio-demographic determinants of obesity indexes in Iran: findings from a nationwide STEPS survey. Health Promot Perspect. 2018;8(3):187-94. http://dx.doi.org/10.15171/hpp.2018.25. PMid:30087841.
Tabrizi JS, Sadeghi-Bazargani H, Farahbakhsh M, Nikniaz L, Nikniaz Z. Prevalence and associated factors of overweight or obesity and abdominal obesity in iranian population: a population-based study of Northwestern Iran. Iran J Public Health. 2018;47(10):1583-92. PMid:30524990.
Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr. 1981;34(8):1617-21. http://dx.doi.org/10.1093/ajcn/34.8.1617. PMid:7270486.
Seo MH, Rhee EJ. Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype. Endocrinol Metab. 2014;29(4):427-34. http://dx.doi.org/10.3803/EnM.2014.29.4.427. PMid:25559571.
Jung CH, Lee WJ, Song KH. Metabolically healthy obesity: a friend or foe? Korean J Intern Med. 2017;32(4):611-21. http://dx.doi.org/10.3904/kjim.2016.259. PMid:28602062.
Stefan N, Haring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1(2):152-62. http://dx.doi.org/10.1016/S2213-8587(13)70062-7. PMid:24622321.
Samocha-Bonet D, Dixit VD, Kahn CR, et al. Metabolically healthy and unhealthy obese: the 2013 Stock Conference report. Obes Rev. 2014;15(9):697-708. http://dx.doi.org/10.1111/obr.12199. PMid:25059108.
Blüher M. Are metabolically healthy obese individuals really healthy? Eur J Endocrinol. 2014;171(6):R209-19. http://dx.doi.org/10.1530/EJE-14-0540. PMid:25012199.
Phillips CM. Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord. 2013;14(3):219-27. http://dx.doi.org/10.1007/s11154-013-9252-x. PMid:23928851.
Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5-6):231-7. http://dx.doi.org/10.1242/dmm.001180. PMid:19407331.
Ashtary-Larky D, Daneghian S, Alipour M, et al. Waist circumference to height ratio: better correlation with fat mass than other anthropometric indices during dietary weight loss in different rates. Int J Endocrinol Metab. 2018;16(4):e55023. http://dx.doi.org/10.5812/ijem.55023. PMid:30464770.
Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487-95. http://dx.doi.org/10.2337/diacare.27.6.1487. PMid:15161807.
Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol. 2007;100(11):1654-8. http://dx.doi.org/10.1016/j.amjcard.2007.06.073. PMid:18036364.
Hinnouho GM, Czernichow S, Dugravot A, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J. 2015;36(9):551-9. PMid:24670711.
Karelis AD, Faraj M, Bastard J-P, et al. The Metabolically Healthy but Obese Individual Presents a Favorable Inflammation Profile. J Clin Endocrinol Metab. 2005;90(7):4145-50. http://dx.doi.org/10.1210/jc.2005-0482. PMid:15855252.
Blaha MJ, Rivera JJ, Budoff MJ, et al. Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31(6):1430-8. http://dx.doi.org/10.1161/ATVBAHA.111.223768. PMid:21474823.
Kutkiene S, Petrulioniene Z, Laucevicius A, et al. Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population. Lipids Health Dis. 2018;17(1):208. http://dx.doi.org/10.1186/s12944-018-0851-0. PMid:30185180.
Koborová I, Gurecká R, Csongová M, et al. Association between metabolically healthy central obesity in women and levels of soluble receptor for advanced glycation end products, soluble vascular adhesion protein-1, and the activity of semicarbazide-sensitive amine oxidase. Croat Med J. 2017;58(2):106-16. http://dx.doi.org/10.3325/cmj.2017.58.106. PMid:28409494.
Chhezom K, Arslan MI, Hoque MM, Biswas SK. Biomarkers of cardiovascular and metabolic diseases in otherwise healthy overweight subjects in Bangladesh. Diabetes Metab Syndr. 2017;11(Suppl Suppl 1):S381-4. http://dx.doi.org/10.1016/j.dsx.2017.03.021. PMid:28285989.
Cure E, Icli A, Uslu AU, et al. Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis. Clin Rheumatol. 2018;37(5):1273-80. http://dx.doi.org/10.1007/s10067-018-4027-0. PMid:29435680.
Dobiás̆ová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34(7):583-8. http://dx.doi.org/10.1016/S0009-9120(01)00263-6. PMid:11738396.
Lee SK, Kim SH, Cho GY, et al. Obesity phenotype and incident hypertension: a prospective community-based cohort study. J Hypertens. 2013;31(1):145-51. http://dx.doi.org/10.1097/HJH.0b013e32835a3637. PMid:23079679.
Dhana K, Koolhaas CM, Van Rossum EF, et al. Metabolically healthy obesity and the risk of cardiovascular disease in the elderly population. PLoS One. 2016;11(4):e0154273. http://dx.doi.org/10.1371/journal.pone.0154273. PMid:27100779.
Submitted date:
08/22/2019
Accepted date:
04/20/2020